About the Product

Description


Artesunate 100mg tablet is an artemisinin derivative anti-malarial formulation used for the effective management of acute malaria infections caused by Plasmodium falciparum and other species.

It works by rapidly targeting and killing malaria parasites, ensuring quick reduction in parasite load and symptomatic relief, including fever and chills.

This tablet is commonly prescribed for acute uncomplicated malaria, severe malaria (as part of combination therapy), and prophylactic support in endemic regions, ensuring effective parasite clearance and recovery.

With rapid onset of action, proven efficacy, and strong acceptance in infectious disease therapy, this formulation strengthens an anti-malarial product portfolio and supports consistent demand in malaria management.

Common side effects may include nausea, vomiting, dizziness, headache, or mild gastrointestinal discomfort. Rarely, allergic reactions, hemolysis, or transient liver enzyme elevations may occur.

Arteslide 100 Tablet is indicated for the treatment of uncomplicated and severe malaria caused by Plasmodium falciparum and other susceptible species, as prescribed by a healthcare professional. It may be used alone or as part of combination therapy depending on clinical guidelines.

For oral use only. Use under strict medical supervision. Complete the full course of therapy to prevent resistance. Caution is advised in patients with liver or kidney disorders.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Artesunate 100mg Tablet in the PCD pharma franchise market?

Artesunate 100mg Tablet has strong demand in the anti-malarial and infectious disease segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-infective and tropical disease care portfolios.

Why should medical distributors include Artesunate 100mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for treatment and management of malaria and related parasitic infections, especially in regions where anti-malarial therapies are commonly prescribed. Artesunate works by rapidly eliminating malaria-causing parasites from the bloodstream, strengthening a reliable anti-malarial product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Artesunate 100mg Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady demand in anti-malarial therapy, institutional and regional healthcare supply opportunities, reliable supply chain support, and good margins when partnering for this anti-infective product.

How can I become a distributor or franchise partner for Artesunate 100mg Tablet?

Medical distributors, stockists, and wholesalers interested in Artesunate 100mg Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.